Skip to content
Medical Health Aged Care

KFSHRC’s Study Named Among Top 10 Most Impactful Papers of 2024

King Faisal Specialist Hospital & Research Centre 2 mins read

research 2025 -8

RIYADH, Saudia Arabia, Jan. 09, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has solidified its reputation as a global leader in medical innovation with its study on fully robotic liver transplants recognized as one of the Top 10 Most Impactful Papers of 2024 by the American Society of Transplantation. 

Building on KFSHRC’s legacy of breakthroughs, the study, ‘Outcomes of Fully Robotic Recipient Living Donor Liver Transplant about the Open Approach,’ represents the world’s first series of fully robotic recipient liver transplants from living donors. The paper highlighted significant advancements in robotic-assisted liver transplantation, including significantly reduced blood loss, shorter hospital stays, and improved cosmetic outcomes compared to traditional open surgery. Importantly, these outcomes were achieved without increasing complication rates, reinforcing KFSHRC’s leadership in setting new surgical innovation and patient care benchmarks.

At the heart of this accomplishment is Professor Dr. Dieter Broering, The Executive Director of the Organ Transplant Centre of Excellence at KFSHRC. A globally recognized leader in robotic-assisted surgeries, Dr. Broering spearheaded in 2024 the world’s first fully robotic left lobe liver transplant. “This achievement highlights the transformative potential of robotic transplant, particularly for procedures previously considered high-risk, and reaffirms our dedication to delivering safer, faster, and more effective outcomes for patients worldwide,” Dr. Broering stated, reflecting on this recognition.

The study was published in the Transplantation Journal, the official monthly publication of The Transplantation Society. With over 58 years of history and over 25,000 annual citations, the journal is a vital platform for pioneering research.

It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 20th globally in the list of the world’s top 250 Academic Medical Centres for the second consecutive year and has been recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. Additionally, it was included in the World’s Best Smart Hospitals list for 2025 by Newsweek magazine.

For more information, visit www.kfshrc.edu.sa or contact our media team at [email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/9d4dc3e0-976d-4931-b569-01dd87ed0bea


Primary Logo

More from this category

  • Medical Health Aged Care
  • 18/04/2025
  • 07:00
Monash University

Experts warn of increased alcohol harms over the Easter long weekend

Heavy alcohol consumption is usually associated with the summer months, not with Easter. But new analysis of Victorian ambulance data shows that there are regularly more than 500 alcohol-related attendances over the Easter long weekend. This heightened level of alcohol harm means the upcoming four-day weekend is the equivalent of four successive Saturday nights, and Victorians should consider their alcohol consumption and plan to stay safe as they prepare for Easter. The analysis reaffirms the findings of other projects led by the National Ambulance Surveillance System (NASS) at Turning Point and Monash University. VicHealth-funded research into the 2022 calendar year…

  • Contains:
  • Medical Health Aged Care
  • 17/04/2025
  • 23:26
Avania

Avania Strengthens Leadership Team With Pivotal Executive Appointments

BILTHOVEN, Netherlands & BOSTON–BUSINESS WIRE– Avania — the leading global MedTech advisory and clinical development partner — today announced the appointments of Jasmine Saba…

  • Contains:
  • Medical Health Aged Care
  • 17/04/2025
  • 22:11
Tilray Brands, Inc.

Tilray Medical Introduces Cannabis Edibles in Australia

Tilray Medical Expands Offerings with Good Supply Brand Medical Cannabis Pastilles for Australian PatientsSYDNEY, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a global company in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, has announced the availability of its medical cannabis edibles, Good Supply Pastilles, to patients in Australia. This launch marks Tilray Medical's first medical cannabis edible offering in the country, providing patients with a sugar-free and vegan-friendly treatment option.Denise Faltischek, Chief Strategy Officer and Head of…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.